Avenue Therapeutics

$6.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-2.06%) Today
+$0.03 (0.49%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ATXI and other stocks, options, ETFs, and crypto commission-free!

About ATXI

Avenue Therapeutics, Inc. engages in acquiring, licensing, developing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, which is intended for the treatment of moderate to moderately severe post-operative pain. Read More The company was founded on February 9, 2015 and is headquartered in New York, NY.

Employees
6
Headquarters
New York, New York
Founded
2015
Market Cap
102.18M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
17.49K
High Today
$6.29
Low Today
$5.96
Open Price
$6.29
Volume
28.56K
52 Week High
$7.98
52 Week Low
$2.08

Collections

ATXI Earnings

-$1.03
-$0.77
-$0.51
-$0.25
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
-$0.43 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.